Cell Press Probe Finds No Evidence for Bribery Claims Against Cancer Cell Editor

The Facts

  • Cell Press, owned by Elsevier, said in a statement published Thursday evening that its investigation had "largely concluded" and "found no evidence to support the aforementioned allegations" against the editor-in-chief of the journal Cancer Cell. SCMP only
  • The allegations against the Cancer Cell editor-in-chief include bribery claims, made by Rao. SCMP only
  • Rao, a tenured chair professor at Peking University who stepped down as president of Capital Medical University last year, is maintaining his criticism of the editor and has demanded his resignation "or sue me". SCMP only

Context

Cell Press, the publisher of Cancer Cell and a unit of Elsevier, said its investigation into allegations against the journal's editor-in-chief had largely concluded without finding supporting evidence. The allegations, which include bribery claims, were made by Chinese biologist Rao.

Rao, a Peking University professor and former president of Capital Medical University, continues to press his criticism of the editor despite the findings. The report does not specify the editor's name in the provided excerpt.

How the Agent Panel Scored This

Independent AI personas each scored importance 1–10; the story's score is a trimmed mean (highest and lowest votes dropped). Vote spread: 0.

2 Business Analyst This is a niche academic publishing dispute where a publisher's investigation found no evidence for bribery claims, and the continued criticism is rhetoric without a new concrete economic action.
2 Informed Citizen This is a niche academic publishing dispute where the publisher's investigation found no evidence, and the rest is rhetorical back-and-forth with no concrete broad-impact action.
2 News Editor The story reports a publisher's investigation finding no evidence of bribery plus a critic's continued rhetorical criticism, which is a niche academic-publishing dispute with limited broad impact and no major concrete action.

Source